{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:27Z","timestamp":1791214047704,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.autrev.2012.01.006","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T02:13:03Z","timestamp":1328235183000},"page":"739-745","source":"Crossref","is-referenced-by-count":203,"title":["Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome"],"prefix":"10.1016","volume":"11","author":[{"given":"I.","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Josse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Decaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dominique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Diot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Landron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Roblot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jouneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.Y.","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.","family":"Tiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Vittecoq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Jouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.01.006_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2011.05.013","article-title":"Pathogenesis and therapies of immune-mediated myopathies","volume":"11","author":"Dalakas","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2009.04.003","article-title":"Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis","volume":"9","author":"Danieli","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","article-title":"Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application","volume":"10","author":"Danieli","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.autrev.2010.09.005","article-title":"Clinical and laboratory aspects of Ro\/SSA-52 autoantibodies","volume":"10","author":"Defendenti","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","article-title":"Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60 kDa antibodies: results of a multicentric study","volume":"10","author":"Ghillani","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0030","article-title":"Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature","author":"Ingegnoli","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0035","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0040","article-title":"Hematological malignancy associated with polymyositis and dermatomyositis","author":"Marie","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.autrev.2011.06.007","article-title":"Therapy of polymyositis and dermatomyositis","volume":"11","author":"Marie","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0050","doi-asserted-by":"crossref","first-page":"A330","DOI":"10.1016\/j.autrev.2009.11.006","article-title":"The geoepidemiology of autoimmune muscle disease","volume":"9","author":"Prieto","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","article-title":"Polymyositis, dermatomyositis and malignancy: a further intriguing link","volume":"9","author":"Zampieri","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0060","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","author":"Marie","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.01.006_bb0065","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kem045","article-title":"Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia","volume":"46","author":"Betteridge","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2012.01.006_bb0070","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.01.006_bb0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","article-title":"Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis","volume":"26","author":"Friedman","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.01.006_bb0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1183\/09031936.00104310","article-title":"Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies","volume":"37","author":"Hervier","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2012.01.006_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-011-0176-8","article-title":"Antisynthetase syndrome","volume":"13","author":"Katzap","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.autrev.2012.01.006_bb0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0095","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2012.01.006_bb0100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00415-004-0449-5","article-title":"The long-term outcome of anti-Jo-1-positive inflammatory myopathies","volume":"251","author":"Sp\u00e4th","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2012.01.006_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis: first of two parts","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis: second of two parts","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"Br J Dermatol"},{"issue":"Suppl. 5","key":"10.1016\/j.autrev.2012.01.006_bb0120","first-page":"1","article-title":"Clinical respiratory physiology: standardized lung function testing: working party report: standardization of lung function tests","volume":"19","author":"Quanjer","year":"1983","journal-title":"Bull Eur Physiopathol Respir"},{"key":"10.1016\/j.autrev.2012.01.006_bb0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.210.2.r99ja15333","article-title":"Interstitial lung disease in association with polymyositis\u2013dermatomyositis: long-term follow-up CT evaluation in seven patients","volume":"210","author":"Akira","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2012.01.006_bb0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005382-199623000-00002","article-title":"High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis","volume":"11","author":"Ikezoe","year":"1996","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.autrev.2012.01.006_bb0135","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short term and long term outcome of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.01.006_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2214\/ajr.169.1.9207505","article-title":"Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT","volume":"169","author":"Mino","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.autrev.2012.01.006_bb0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thorax.58.2.143","article-title":"Radiological versus histological diagnosis in UIP and NSIP: survival implications","volume":"58","author":"Flaherty","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2012.01.006_bb0150","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1440-1843.2009.01626.x","article-title":"Diagnosing fibrotic lung disease: when is high-resolution computed tomography sufficient to make a diagnosis of idiopathic pulmonary fibrosis?","volume":"14","author":"Schmidt","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.autrev.2012.01.006_bb0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2483071378","article-title":"Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study","volume":"249","author":"Shin","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2012.01.006_bb0160","first-page":"1520","article-title":"High resolution computed tomography in early scleroderma lung disease","volume":"18","author":"Warrick","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.01.006_bb0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.289.6438.151","article-title":"Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease","volume":"289","author":"Bernstein","year":"1984","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2012.01.006_bb0175","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.163.5.1281","article-title":"Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis","volume":"163","author":"Bunn","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0180","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2169\/internalmedicine.44.527","article-title":"Autoantibodies to aminoacyl-tRNA synthetases","volume":"44","author":"Hirakata","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2012.01.006_bb0190","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1084\/jem.160.2.420","article-title":"Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody","volume":"160","author":"Mathews","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s100670070030","article-title":"Clinical and serological aspects of patients with anti-Jo-1 antibodies\u2014an evolving spectrum of disease manifestations","volume":"19","author":"Schmidt","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.01.006_bb0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0002-9343(90)90149-8","article-title":"Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase)","volume":"88","author":"Targoff","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1445-5994.2010.02164.x","article-title":"Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies","volume":"41","author":"Dugar","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2012.01.006_bb0210","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.rmed.2009.05.001","article-title":"Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia","volume":"103","author":"Fischer","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2169\/internalmedicine.44.319","article-title":"Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension","volume":"44","author":"Handa","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0220","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1378\/chest.08-2233","article-title":"Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature","volume":"135","author":"Kalluri","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2012.01.006_bb0225","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1378\/chest.07-2235","article-title":"A 34-year-old man presenting with gradual onset of shortness of breath and interstitial lung disease","volume":"133","author":"Rubinowitz","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2012.01.006_bb0230","first-page":"609","article-title":"Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies","volume":"23","author":"Sato","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.01.006_bb0235","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.21883","article-title":"Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis","volume":"54","author":"Yamasaki","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.01.006_bb0240","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","article-title":"Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients","volume":"77","author":"Vancsa","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2012.01.006_bb0245","first-page":"681","article-title":"Periarticular calcifications and arthropathy as the first manifestation of polymyositis","volume":"21","author":"Marie","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.01.006_bb0250","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/40.9.1072","article-title":"Intravenous immunoglobulins and octreotide as treatment of intestinal pseudo-obstruction revealing a recurrence of polymyositis","volume":"40","author":"Marie","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2012.01.006_bb0255","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00000441-200612000-00003","article-title":"Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association","volume":"332","author":"Tweezer-Zaks","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.autrev.2012.01.006_bb0260","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08916930600622884","article-title":"Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies","volume":"39","author":"Yoshifuji","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2012.01.006_bb0265","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/08916931003592307","article-title":"Insights in the autoimmunity of myasthenia gravis","volume":"43","author":"De Baets","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2012.01.006_bb0270","doi-asserted-by":"crossref","first-page":"A383","DOI":"10.1016\/j.autrev.2009.11.011","article-title":"Geoepidemiology of myasthenia gravis","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.01.006_bb0275","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2012.01.006_bb0280","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.01.006_bb0285","first-page":"169","article-title":"Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome","volume":"35","author":"Legault","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.01.006_bb0290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/RHU.0b013e31817d116f","article-title":"Malignancy in the setting of the anti-synthetase syndrome","volume":"14","author":"Rozelle","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.01.006_bb0295","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/rheumatology\/keg473","article-title":"Jo-1 syndrome with associated poorly differentiated adenocarcinoma","volume":"43","author":"Watkins","year":"2004","journal-title":"Rheumatology (Oxford)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T01:33:50Z","timestamp":1561253630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1568997212000201"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.01.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}